U.S. markets closed

Enlivex Therapeutics Ltd. (ENLV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.05+0.05 (+0.42%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 1/23/2021
Current
9/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
162.24M79.97M68.13M62.84M86.72M
Enterprise Value 3
134.74M50.13M35.57M49.38M73.25M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
5.692.652.134.566.29
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-15.61-27.39-17.07-66.91-24.90

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 341.60%
S&P500 52-Week Change 318.43%
52 Week High 316.94
52 Week Low 33.59
50-Day Moving Average 310.30
200-Day Moving Average 38.29

Share Statistics

Avg Vol (3 month) 3226.48k
Avg Vol (10 day) 3131.57k
Shares Outstanding 513.46M
Float 8.19M
% Held by Insiders 133.52%
% Held by Institutions 113.47%
Shares Short (Dec 30, 2020) 4202.61k
Short Ratio (Dec 30, 2020) 40.52
Short % of Float (Dec 30, 2020) 42.29%
Short % of Shares Outstanding (Dec 30, 2020) 41.50%
Shares Short (prior month Nov 29, 2020) 4101.67k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:8
Last Split Date 3Mar 05, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-21.22%
Return on Equity (ttm)-41.75%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -8.68M
Net Income Avi to Common (ttm)-9.03M
Diluted EPS (ttm)-0.74
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)28.18M
Total Cash Per Share (mrq)2.09
Total Debt (mrq)682k
Total Debt/Equity (mrq)2.39
Current Ratio (mrq)7.23
Book Value Per Share (mrq)2.12

Cash Flow Statement

Operating Cash Flow (ttm)-6.9M
Levered Free Cash Flow (ttm)-4.04M